Slide 1: Second Quarter 2026 Earnings Presentation
Second Quarter 2026 Earnings Presentation July 30, 2026
Slide 2: Forward-Looking Statements & Non-GAAP Financial Measures
Forward-Looking Statements & Non-GAAP Financial Measures This presentation (the “Presentation”) includes statements that are forward-looking statements within the meaning of applicable securities laws. All statements other than statements of historical facts are forward-looking statements. Forward-l
Slide 3: Arxis Performance Update
Arxis Performance Update Q2 2026 Financial Highlights CY 2026 Guidance Adjusted Adjusted Increasing Revenue EBITDA(1) EBITDA Margin(1) Guidance Margin(1_ Revenue $501M $211M 42.2% $1,960M - $1,980M +100M 38% 390 bps Vs. prior midpoint 25% Adjusted EBITDA(2) Year-over-Year Year-over-Year Year-over-Ye
Slide 4: Premier Supplier of Proprietary Engineered Components
Premier Supplier of Proprietary Engineered Components Common Business Model Attributes Across Arxis Custom, Highly- Design Into Mission- Outsized Value-to-Cost Cutting-Edge Performance Engineered Solutions Critical Applications Ratio at the Extreme Product IP(1), (2) End Market Mix(1) Segment Breakd
Slide 5: A Differentiated Model for Long-Term Growth
A Differentiated Model for Long-Term Growth World-Class High Growth Unified Engineering and New Business Repeatable M&A and Diverse Decentralized R&D Machine Engine End Markets Org Structure Capabilities Tailwinds Differentiation Arxis EDGE 5
Slide 6: Executing Our M&A Strategy – Recent Acquisitions
Executing Our M&A Strategy – Recent Acquisitions Acquisition Segment Business Overview Consistent Business Model Scores Designer and manufacturer of Mechanical mission-critical, intricate rubber-to- Components Closed January 2026 metal-bonded seals and assemblies Highly engineered custom component
Slide 7: Omnetics: The Arxis–Arcline Partnership in Action
Omnetics: The Arxis–Arcline Partnership in Action Operating Expertise Investment Expertise Partnered in sourcing the acquisition Partnered in sourcing the acquisition opportunity opportunity Evaluated the strategic and operational Contributed investment expertise fit Partnered on financial
Slide 8: Q2 2026 Financial Results
Q2 2026 Financial Results Revenue Adjusted EBITDA(1) Free Cash Flow(1) 42.2% $501M $211M $127M $400M 38.4% $154M $35M +25% YoY +38% YoY +261% YoY Q2 2025 Q2 2026 Q2 2025 Q2 2026 Q2 2025 Q2 2026 • Revenue increased +25% YoY • Continued operational improvements • Strong earnings and improved net worki
Slide 9: Capital Structure Update
Capital Structure Update Net Leverage(1) Financial flexibility to support disciplined (Net Debt / Adj. EBITDA(1)) M&A and growth • Paid down $946M Term Loan B in April with portion 4.2x 4.0x of IPO proceeds • Repriced Term Loan B at 25 bps lower spread, reducing annual cash interest expense by appro
Slide 10: Full Year 2026 Guidance
Full Year 2026 Guidance Current Guidance Prior Guidance Vs. Prior Guidance(3) $1,960M - $1,980M $1,860M - $1,880M +$100M Revenue 23% - 24% reported YoY% 17% - 18% reported YoY % 5% increase 20% - 21% organic(2) YoY% 14% -16% organic(2) YoY % $790M - $800M $720M - $730M +$70M Adj. EBITDA(1) ~40.4% ma
Slide 11: Full Year 2026 End Market Assumptions
Full Year 2026 End Market Assumptions 2026 Arxis Assumed Growth by End Market(1) Defense & Space Commercial Aerospace Industrial Technology 47% of revenue(2) 23% of revenue(2) 30% of revenue (2) Approximately 20% organic(1) growth across all three end markets (1) Management organic revenue growth es
Slide 12: Appendix
Appendix
Slide 13: Additional 2026 Inputs
Additional 2026 Inputs 2026 Capital Expenditures $63M Interest Expense $130M(1) Effective Tax Rate 29.0% - 30.0% Depreciation & Amortization $206M Share-Based Compensation $155M Tax Receivable Agreement (TRA) Expense $13M Convertible Common Stock Compensation Expense $16M Common Shares Outstanding 4
Slide 14: Non-GAAP reconciliations
Non-GAAP reconciliations Adjusted EBITDA and Adjusted EBITDA Margin % (non-GAAP) Adjusted EBITDA is defined as net income (loss), adjusted to exclude interest expense, net, income tax expense (benefit), depreciation and amortization, acquisition and integration costs, restructuring costs, transactio
Slide 15: Adjusted EBITDA and Margin Reconciliation
Adjusted EBITDA and Margin Reconciliation Three Months Ended June 30, Six Months Ended June 30, Year Ended December 31, (in thousands, except percentages) 2026 2025 2026 2025 2025 Net income (loss) $ (4,909) $ (29,256) $ 48,400 $ (33,580) $ 45,989 Interest expense, net 39,427 57,356 83,385 125,616 2
Slide 16: Free Cash Flow Reconciliation
Free Cash Flow Reconciliation Three Months Ended June 30, Six Months Ended June 30, (in thousands) 2026 2025 2026 2025 Net cash provided by operating activities $ 137,885 $ 47,843 $ 174,354 $ 68,605 Less: Capital expenditures (10,587) (12,600) (22,290) (21,395) Free Cash Flow $ 127,298 $ 35,244 $ 15
Slide 17: Net Leverage Reconciliation
Net Leverage Reconciliation (in thousands, except multiples) June 30, 2026 March 31, 2026 December 31, 2025 Total debt $ 1,718,137 $ 2,652,495 $ 2,633,312 Add: Unamortized deferred financing costs 15,523 27,225 28,159 Less: Cash and cash equivalents (494,693) (238,918) (250,303) Total net debt $ 1,2